Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...

With Ring as their new primary sponsor, the Thorns are saying goodbye to the longstanding jersey sponsorship it had with ...

President Donald J. Trump’s execu­tive order eliminating USAID has sent shockwaves across the globe, particularly in aid-dependent na­tions, most of which are in Africa. In line with the saying that ...

Tristan Schukraft, the so-called CEO of Everything Gay, raised eyebrows when he spent $17 million to buy up the Pines ...

The U.N.'s Angeli Achrekar reports that many clinics have closed, despite exemptions in the policy. She fears mortality will ...

According to data from amfAR, the Foundation for AIDS Research, about 1.3 million people are on HIV/AIDS treatment in Kenya, ...

A lawsuit by three nonprofit s argues that executive orders from President Trump limit the ability to provide health and ...

The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...

Despite breakthroughs in HIV treatment and prevention worldwide, critical challenges such as stigma, unequal access and ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...

Three New York City-based LGBTQ political clubs delivered a letter to Governor Kathy Hochul and top lawmakers in Albany urging them to increase funding and ...